Clinical experience with PMMA membrane

Contributions to Nephrology

Volumn 125, Issue , 1999, Pages 213-221

  Albertazzi, Alberto ^a,c   Bonomini, Mario ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BIOMATERIAL; POLY(METHYL METHACRYLATE);

AMYLOIDOSIS; ARTICLE; ARTIFICIAL MEMBRANE; BLOOD; CLINICAL TRIAL; CROSSOVER PROCEDURE; INSTRUMENTATION; MOLECULAR WEIGHT; NERVE CONDUCTION; NUTRITIONAL DISORDER; PERIPHERAL NEUROPATHY; PERMEABILITY; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; UREMIA;

AMYLOIDOSIS; BETA 2-MICROGLOBULIN; BIOCOMPATIBLE MATERIALS; CROSS-OVER STUDIES; MEMBRANES, ARTIFICIAL; MOLECULAR WEIGHT; NEURAL CONDUCTION; NUTRITION DISORDERS; PERIPHERAL NERVOUS SYSTEM DISEASES; PERMEABILITY; POLYMETHYL METHACRYLATE; PROSPECTIVE STUDIES; RENAL DIALYSIS; UREMIA;

EID: 0032614340     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (37)

1. Powell D, Bergstrom J, Dzurik R, Gulyassay P, Lockwood D, Phillips L: Toxins and inhibitors in chronic renal failure. Am J Kidney Dis 1986;4:292-299.
2. Vanholder R, De Smet R, Hsu C, Vogeleere P, Ringoir S: Uremic toxicity: The middle molecule hypothesis revisited. Semin Nephrol 1994;14:205-218.
3. Geiyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunimoto T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T, Cohen A, Schmid K: A new form of amyloid protein associated with chronic hemodialysis was identified as beta-2-microglobulin. Biochem Biophys Res Commun 1985; 129:701-706.
4. Bardin T, Zingraff J, Juntz D, Drucke T: Dialysis-related amyloidosis. Nephrol Dial Transplant 1986;1:151-154.
5. Hakim RM: Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 1993; 44:484-494.
6. Basile C, Drucke T: Dialysis membrane biocompatibility. Nephron 1989;52:113-118.
7. Sakai Y, Tanzawa H: Poly(methyl methacrylate) membranes. J Appl Sci 1978;22:1805-1818.
8. 2-M removal: Long-term multicentre study on beta-2-microglobulin removal by PMMA BK membrane. Nephrol Dial Transplant 1991;6(suppl 2): 69-74.
9. Hakim RM, Fearon DT, Lazarus JM: Biocompatibility of dialysis membranes: Effects of chronic complement activation. Kidney Int 1984;26:194-200.
10. Tetta C, Turello E, Salomone M, Priolo G, Segoloni G, Camussi G: Production of cytokines in hemodialysis. Blood Purif 1990;8:337-346.
11. Albertazzi A, Bonomini M, Di Paolo B: Electrophysiological and biofunctional abnormalities in uremic neuropathy. Nephrology, vol I. Proc XIth International Congress of Nephrology. Tokyo, Springer, 1991, pp 399-408.
12. Albertazzi A, Bonomini M, Cappelli P: Neurological and psychiatric disorders in renal diseases; in Suki WN, Massry SG (eds): Suki and Massry's Therapy of Renal Diseases and Related Disorders, ed 3. Boston, Kluwer Academic, 1998, pp 855-873.
13. Di Paolo B, Di Marco T, Cappelli P, Spisni C, Del Rosso G, Palmieri PF, Evangelista M, Albertazzi A: Electrophysiological aspects of nervous conduction in uremia. Clin Nephrol 1988;29:253-260.
14. Raskin NH, Fishman RA: Neurologic disorders in renal failure. N Engl J Med 1976;294:143-148.
15. Teschan PE, Ginn HE, Bourne JR, Ward JW, Amel B, Nummally JC, Musso M, Vaughn WK: Quantitative indices of clinical uremia. Kidney Int 1979;15:676-697.
16. Di Paolo B, Di Marco T, Cappelli P, Albertazzi A: Polymethylmethacrylate in chronic hemodialysis. Is it of benefit in patients with uremic neuropathy? Trans Am Soc Artif Intern Organs 1987;33: 293-296.
17. Albertazzi A, Di Paolo B, Cappelli P, Spisni C, Del Rosso G: Evoked potentials in uremia. Contrib Nephrol. Basel, Karger, 1985, vol 45, pp 60-68.
18. Acchiardo SR, Moore LW, Latour PA: Malnutrition as the main factor in morbidity of hemodialysis patients. Kidney Int 1983;24(suppl 16):199-203.
19. Hakim RM, Levin N: Malnutrition in hemodialysis patients. Am J Kidney Dis 1993;21:125-137.
20. Lazarus M: Nutrition in hemodialysis patients. Am J Kidney Dis 1993;21:99-105.
21. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM: Amino acid and albumin losses during hemodialysis. Kidney Int 1994;46:830-837.
22. Lindsay RM, Bergstrom J: Membrane biocompatibility and nutrition in maintenance haemodialysis patients. Nephrol Dial Transplant 1994;9(suppl 2):150-155.
23. Gutierrez A, Alvestrand A, Wahren J, Bergstrom J: Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 1990;38:487-494.
24. Parker TF III, Wingard RL, Husni L, Ikizler TA, Parker RA, Hakim RM: Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients. Kidney Int 1996;49: 551-556.
25. Goldwasser P, Mittman M, Antignani A, Burrel D, Michel M, Collier T, Avram MM: Predictors of mortality on hemodialysis. J Am Soc Nephrol 1993;3:1613-1622.
26. Massry SG: The toxic effects of parathyroid hormone in uremia. Semin Nephrol 1983;3:306-328.
27. Haag-Weber M, Mai B, Cohen G, Horl WH: GIP and DIP: A new view of uraemic toxicity. Nephrol Dial Transplant 1994;9:346-347.
28. Niwa T, Aiuchi T, Nakaya K, Emoto Y, Miyazaki T, Maeda K: Inhibition of mitochondrial respiration by furancarboxylic acid accumulated in uremic serum in its albumin-bound and nondialyzable form. Clin Nephrol 1993;39:92-96.
29. Anderstam B, Mamoun A-H, Sodersten P, Bergstrom J: Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat. J Am Soc Nephrol 1996;7:2453-2460.
30. Kobayashi H, Ono T, Yamamoto N, Hashimoto T, Fukuda T, Yamada S, Kai C, Kataoka H, Kobayashi T, Sonoda T: Removal of high molecular weight substances with large-pore-size membrane (BK-F). Kidney Dial 1993;34(suppl):154-157.
31. Bonomini M, Fiederling B, Bucciarelli T, Manfrini V, Di Ilio C, Albertazzi A: A new polymethylmethacrylate membrane for hemodialysis. Int J Artif Organs 1996;19:232-239.
32. Calzavara P, Mottola A, Caberlotto L, Da Porto A, Amici G, Calconi G: Protein removal by a new polymethylmethacrylate membrane. Int J Artif Organs 1996;19:493-494.
33. Saito A, Naito M, Hirohata M: Dialytic removal of middle molecular and low molecular weight proteins; in Atsumi K, Maekawa M, Ota K (eds): Progress in Artificial Organs. Cleveland, ISAO Press, 1983, pp 412-416.
34. Naito H, Miyazaki T: Haemodialysis with protein permeable membranes. Nephrol Dial Transplant 1989;4(suppl):78-82.
35. Nensel U, Rockel A, Hillebradt T, Bartel J: Dialyzer permeability for low-molecular-weight proteins. Blood Purif 1994;12:128-134.
36. Vanholder R, Van Loo A, Dhondt AM, Glorieux G, De Smet R, Ringoir S: Second symposium on uraemic toxicity. Nephrol Dial Transplant 1995;10:414-418.
37. Tanaka H: Quality of membrane. Contrib Nephrol. Basel, Karger, 1993, vol 103, pp 112-124.